Loading clinical trials...
Loading clinical trials...
Physiological Response to U-LABA/ICS With Emphasis on Exercise Performance, Vilanterol
Conditions
Interventions
Vilanterol and Fluticasone Furoate (low dose)
Vilanterol and Fluticasone Furoate (high dose)
+1 more
Locations
1
Denmark
August Krogh Building
Copenhagen, DK, Denmark
Start Date
October 3, 2023
Primary Completion Date
July 15, 2026
Completion Date
December 1, 2026
Last Updated
April 10, 2025
NCT06474754
NCT07252778
NCT06067100
NCT07215052
NCT07525479
NCT07473193
Lead Sponsor
Morten Hostrup, PhD
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions